BioCentury
ARTICLE | Clinical News

Techniclone International Corp. regulatory update

October 9, 1995 7:00 AM UTC

TCLN's radiolabeling facility in Oklahoma City received a license from the Nuclear Regulatory Commission, enabling the company to begin its multicenter Phase II/III trial of Oncolym in lymphoma patie...